1. Pink Sheet

Generic Drug Approvals Still Winning The Pandemic At US FDA

 
• By Derrick Gingery

Productivity remains high as full ANDA approvals reached a FY 2020 peak and complete responses dropped to another low in June.

Generics
The FDA said several recent ANDA approvals came through its commitment to work past a goal date if approval was imminent. • Source: Shutterstock

Generic drug sponsors notched a double win with the US Food and Drug Administration in June: increased application clearances and reduced complete responses.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from User Fees

More from Pathways & Standards